CSL is seeking a Director, BD Early Stage to lead assessment of early-stage external innovation from Due Diligence Stage 2 to negotiation of a Non-Binding Offer. The role combines scientific insight, clinical and regulatory awareness with strategic enterprise judgment to guide investment decisions and portfolio positioning.
You will deliver investment-ready assessments, translate complex data into clear recommendations for senior leaders, and prioritize opportunities within the TA strategy while
#J-18808-Ljbffr
